Seres Therapeutics's total assets for Q2 2026 were $101.59M, a decrease of -13.63% from the previous quarter. CH:MCRB total liabilities were $67.05M for the fiscal quarter, a -26.41% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.